$3.96
-0.19[-4.58%]
At close: Apr 25
$3.96
0[0.00%]
After Hours: 7:59PM EDT
Novavax reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Novavax using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | NVAX | Q1 | -$3.41 | -$0.92 | — | — | $80.95M | $100.60M | — | — | Get Alert |
02/28/2024 | AM | NVAX | Q4 | -$2.28 | -$0.45 | -$1.47 | -226.67% | $357.40M | $321.65M | $291.34M | -9.42% | Get Alert |
11/09/2023 | AM | NVAX | Q3 | -$2.15 | -$1.83 | -$1.26 | 31.15% | $734.58M | $158.54M | $186.99M | 17.94% | Get Alert |
08/08/2023 | AM | NVAX | Q2 | -$6.53 | -$1.24 | $0.58 | 146.77% | $185.93M | $257.62M | $424.43M | 64.75% | Get Alert |
05/09/2023 | AM | NVAX | Q1 | $2.56 | -$3.46 | -$3.41 | 1.45% | $703.97M | $87.61M | $80.95M | -7.60% | Get Alert |
02/28/2023 | PM | NVAX | Q4 | -$11.18 | -$0.92 | -$2.28 | -147.83% | $222.20M | $383.14M | $357.40M | -6.72% | Get Alert |
11/08/2022 | PM | NVAX | Q3 | -$4.31 | $1.57 | -$2.15 | -236.94% | $178.84M | $586.25M | $734.58M | 25.30% | Get Alert |
08/08/2022 | PM | NVAX | Q2 | -$4.75 | $6.36 | -$6.53 | -202.67% | $298.02M | — | $185.93M | — | Get Alert |
05/09/2022 | PM | NVAX | Q1 | -$3.05 | $2.69 | $2.56 | -4.83% | $447.23M | $845.20M | $703.97M | -16.71% | Get Alert |
02/28/2022 | PM | NVAX | Q4 | -$2.70 | -$1.80 | -$11.18 | -521.11% | $276.66M | $331.79M | $222.20M | -33.03% | Get Alert |
11/04/2021 | PM | NVAX | Q3 | -$3.21 | -$3.91 | -$4.31 | -10.23% | $157.02M | $334.62M | $178.84M | -46.55% | Get Alert |
08/05/2021 | PM | NVAX | Q2 | -$0.30 | -$3.63 | -$4.75 | -30.85% | $35.54M | $387.87M | $298.02M | -23.17% | Get Alert |
05/10/2021 | PM | NVAX | Q1 | -$0.58 | -$3.60 | -$3.05 | 15.28% | $3.38M | $233.90M | $447.23M | 91.21% | Get Alert |
03/01/2021 | PM | NVAX | Q4 | -$1.13 | -$1.49 | -$2.70 | -81.21% | $8.82M | $304.88M | $276.66M | -9.26% | Get Alert |
11/09/2020 | PM | NVAX | Q3 | -$0.74 | $1.73 | -$3.21 | -285.55% | $2.51M | $230.56M | $157.02M | -31.89% | Get Alert |
08/10/2020 | PM | NVAX | Q2 | -$1.69 | -$0.42 | -$0.30 | 28.57% | $3.36M | $39.58M | $35.54M | -10.21% | Get Alert |
05/11/2020 | PM | NVAX | Q1 | -$2.20 | -$0.78 | -$0.58 | 25.64% | $3.98M | $1.74M | $3.38M | 94.08% | Get Alert |
03/11/2020 | PM | NVAX | Q4 | -$2.60 | -$1.06 | -$1.13 | -6.60% | $6.13M | — | $8.82M | — | Get Alert |
11/07/2019 | PM | NVAX | Q3 | -$2.40 | -$0.98 | -$0.74 | 24.49% | $7.74M | $2.53M | $2.51M | -0.91% | Get Alert |
Novavax (NVAX) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $-1.47, which missed the estimate of $-0.45.
The Actual Revenue was $291.3M, which missed the estimate of $321.6M.
Browse earnings estimates, EPS, and revenue on all stocks.